TrumpRx pricing, cervical cancer, NIH, WHO: Morning Rounds

Start your day with the latest news in health and medicine by subscribing to STAT’s free newsletter Morning Rounds. Sign up now to get your daily dose of information.

The truth behind TrumpRx drug prices

President Trump recently announced the launch of the TrumpRx website, claiming to offer the lowest prices globally for 43 brand-name drugs. However, a closer look reveals that many of these drugs are already available in generic forms at significantly lower prices.

Mark Cuban, the entrepreneur behind Cost Plus Drugs, pointed out that several of the drugs listed on TrumpRx have generic alternatives that are much more affordable. To learn more about where to find these cheaper prices, read the full analysis from STAT.

A new rule puts NIH grant reviewers at risk

A recent rule proposed by the Trump administration has raised concerns about the politicization of NIH grant decisions. The finalized rule reclassifies federal employees as political appointees, potentially jeopardizing the impartiality of grant reviews.

Despite overwhelming opposition to the rule, it was put into effect last week, sparking worries about the future of NIH funding. For a detailed analysis of the implications of this rule, read the latest report from STAT.

China criticizes U.S. for WHO withdrawal

During a recent meeting of the World Health Organization’s executive board, a Chinese representative criticized the United States for its withdrawal from the organization. The representative emphasized the importance of upholding international law over national policies.

The discussion, which also touched on Argentina’s withdrawal from the WHO, highlighted global concerns about the impact of these exits. To delve deeper into the implications of these withdrawals, read the full coverage from STAT’s Helen Branswell.

Who will take care of you?

Renowned neurologist and STAT columnist Jason Karlawish explores the evolving landscape of dementia care in his latest column. He emphasizes the importance of asking a simple yet crucial question: Who will take care of you?

As the field of dementia care continues to evolve, Karlawish sheds light on the changing standards and practices in caregiving. To learn more about the future of dementia care and the role of patient autonomy, dive into his insightful analysis.

Survey says: Most women don’t want to do their own cervical cancer screenings

While at-home cervical cancer screenings are gaining popularity, a recent survey reveals that most women still prefer traditional clinic-based testing. The study, published in JAMA Network Open, found that 61% of women prefer in-office screenings over self-sampling.

Factors like past experiences of prejudice or discrimination influence women’s preferences for screening methods. To explore the findings of this survey and understand the nuances of cervical cancer screening, delve into the full report.

What we’re reading

• Newly revealed emails undermine RFK Jr testimony about 2019 Samoa trip ahead of measles outbreak, The Guardian

• The FDA quietly slapped more restrictions on the birth control implant, Autonomy News

• First Opinion: As a scientist and NFL widow, I am furious about a recent NFL Players Association-funded CTE study, STAT
• Epstein files reveal deeper ties to scientists than previously known, Nature
• White House looks for more drug pricing deals to add to TrumpRx, STAT

Stay informed with today’s STAT Mini crossword and test your knowledge!